Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ferris

Showing results (621-630 of 818) with videos related to

Pageof 82
Sort By:
Journal for Immunotherapy of Cancer|June 23, 2016
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common ruleHoward L Kaufman, Lisa H Butterfield, Pierre G Coulie, et al.
Ophthalmology|February 15, 2016
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular EdemaHenry E Wiley, Darby J S Thompson, Clare Bailey, et al.
Frontiers in Oncology|April 12, 2021
Safety and Feasibility of Surgery for Oropharyngeal Cancers During the SARS-CoV-2-PandemicPhilippe Gorphe, Bruno Grandbastien, Andreas Dietz, et al.
Oral Oncology|March 24, 2023
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neckNicole N Scheff, Marci L Nilsen, Jinhong Li, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neckJohn A Vargo, Robert L Ferris, James Ohr, et al.
Ophthalmology|October 14, 2014
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)Michael M Altaweel, Ebenezer Daniel, Daniel F Martin, et al.
Ophthalmology|June 22, 2010
Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31Emily Y Chew, Jonghyeon Kim, Robert D Sperduto, et al.
American Journal of Ophthalmology|February 5, 2003
A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocolRoy W Beck, Pamela S Moke, Andrew H Turpin, et al.
Cancers|June 18, 2020
Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck CancerJulie E Bauman, James Ohr, William E Gooding, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2016
Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck CancerDiane C Ling, John A Vargo, Robert L Ferris, et al.
Pageof 82

Showing results (621-630 of 818) with videos related to

Sort By:
Pageof 82
Journal for Immunotherapy of Cancer|June 23, 2016
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common ruleHoward L Kaufman, Lisa H Butterfield, Pierre G Coulie, et al.
Ophthalmology|February 15, 2016
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular EdemaHenry E Wiley, Darby J S Thompson, Clare Bailey, et al.
Frontiers in Oncology|April 12, 2021
Safety and Feasibility of Surgery for Oropharyngeal Cancers During the SARS-CoV-2-PandemicPhilippe Gorphe, Bruno Grandbastien, Andreas Dietz, et al.
Oral Oncology|March 24, 2023
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neckNicole N Scheff, Marci L Nilsen, Jinhong Li, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neckJohn A Vargo, Robert L Ferris, James Ohr, et al.
Ophthalmology|October 14, 2014
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)Michael M Altaweel, Ebenezer Daniel, Daniel F Martin, et al.
Ophthalmology|June 22, 2010
Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31Emily Y Chew, Jonghyeon Kim, Robert D Sperduto, et al.
American Journal of Ophthalmology|February 5, 2003
A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocolRoy W Beck, Pamela S Moke, Andrew H Turpin, et al.
Cancers|June 18, 2020
Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck CancerJulie E Bauman, James Ohr, William E Gooding, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2016
Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck CancerDiane C Ling, John A Vargo, Robert L Ferris, et al.
Pageof 82